This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Nanjing Immunophage Biomedical Co., Ltd., Nanjing Immunophage Biotech Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
1 out of 1 Years Active: 2026
Title: Jianfei Wang - Innovator in Cancer Treatment
Introduction
Jianfei Wang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biomedical research, particularly in cancer treatment. His innovative work focuses on targeting specific regulatory cells to enhance therapeutic outcomes.
Latest Patents
Jianfei Wang holds a patent for "Methods and compositions for targeting Tregs using CCR8 inhibitors." This invention provides compounds of Formula (I) that can be utilized as CCR8 inhibitors. These compounds are designed for the treatment or prevention of cancer by targeting tumor-specific T regulatory cells.
Career Highlights
Wang is associated with Nanjing Immunophage Biomedical Co., Ltd., where he applies his expertise in developing novel therapeutic strategies. His work is instrumental in advancing cancer treatment methodologies.
Collaborations
Wang collaborates with Kin Chiu Fong, contributing to the innovative research environment at Nanjing Immunophage Biomedical Co., Ltd. Their combined efforts aim to push the boundaries of cancer treatment.
Conclusion
Jianfei Wang's contributions to cancer research through his innovative patent highlight his role as a key figure in the biomedical field. His work continues to pave the way for new therapeutic approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile